Peak body for Generic and Biosimilar medicines welcomes legislation to inform patients about medicine shortages

Canberra, ACT

New laws, aimed at better informing patients about medicine shortages, have been applauded by the Generic and Biosimilar Medicines Association (GBMA).

Australian patients will have access to timely and relevant information about the supply of critical and life-saving medicines, including advice about how to minimize the impact of a shortage, with the Parliament passing the Morrison Government’s landmark legislation.

The GBMA has been working closely with the Government and stakeholders to harness support for the passage of this important legislation.

The Chair of GBMA, Mr Sylvain Vigneault, said medicine shortages are a global challenge and Australia was showing leadership on such a complex issue.
“This is a significant development that will lead to better protection of our most vulnerable Australians.” Mr Vigneault said.

“Now, industry, community pharmacy, hospitals and the Government will collaborate more effectively to ensure information about the supply of vital medicines reaches those who need it.”

“Patients need certainty and clarity on when there is likely to be a shortage of vital medicines, unintentional or otherwise,” said Mr Vigneault said.

“This will give Australia a more effective system to red flag potential issues before they impact on patients.”